52910
4,7,13,16,21,24-六氧-1,10-二氮双环[8.8.8]二十六烷
puriss., ≥99.0% (T)
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C18H36N2O6
化学文摘社编号:
分子量:
376.49
EC Number:
245-962-4
UNSPSC Code:
12350000
PubChem Substance ID:
Beilstein/REAXYS Number:
620282
MDL number:
InChI key
AUFVJZSDSXXFOI-UHFFFAOYSA-N
InChI
1S/C18H36N2O6/c1-7-21-13-14-24-10-4-20-5-11-25-17-15-22-8-2-19(1)3-9-23-16-18-26-12-6-20/h1-18H2
SMILES string
C1COCCN2CCOCCOCCN(CCO1)CCOCCOCC2
grade
puriss.
assay
≥99.0% (T)
mp
68-71 °C (lit.), 69-73 °C
法规信息
新产品
此项目有
Dynamers at the solid-liquid interface: controlling the reversible assembly/reassembly process between two highly ordered supramolecular guanine motifs.
Artur Ciesielski et al.
Angewandte Chemie (International ed. in English), 49(11), 1963-1966 (2010-02-06)
Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector.
R A Ferrieri et al.
Nuclear medicine and biology, 20(3), 367-369 (1993-04-01)
Jeff E Prest et al.
Journal of chromatography. A, 1260, 239-243 (2012-09-20)
This work shows how the inclusion of cryptand 222 as a leading electrolyte additive in isotachophoresis affects the electrophoretic mobilities of alkali metal cations. Using isotachophoresis the separation of alkali metals can be difficult due to the similar electrophoretic mobilities
S M Moerlein et al.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes, 40(9), 741-743 (1989-01-01)
Radiopharmaceutical solutions of 2-[18F]fluoro-2-deoxy-D-glucose (2-[18F]FDG) prepared via an aminopolyether-supported nucleophilic-substitution mechanism were analyzed for contaminant 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo-[8,8,8]-hexacosane (Kryptofix 2.2.2). Washing the C18-immobilized [18F]fluoro-tetraacetylated intermediate with 10 mL 0.1 M HCl was found to remove impurity Kryptofix 2.2.2 from the final product.
Ying Ma et al.
Nuclear medicine and biology, 29(1), 125-129 (2002-01-12)
A high-performance liquid chromatography-tandem mass spectrometric method (LC/MS/MS) was developed and validated for the quantitative analysis of Kryptofix (K-222) in the radiopharmaceuticals of 2-deoxy-2-[(18)F] fluoro-D-glucose (2-[(18)F]FDG) and 3-(3-((3-fluoropropyl)thio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine (FPTZTP). With an internal standard, the limit of quantitation for K-222 was
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持